Company news

Sernova Biotherapeutics Inc news in 2019

Sernova Biotherapeutics Inc's news releases, calls and decks from 2019, newest first.

View company

Sernova Announces Biotech Veteran as New Chief Financial Officer

October 24, 2019

InvestmentPitch Media Video Discusses Sernova Corp's Further Validation of Cell Pouch and Therapeutic Cell Performance in Type-1 Diabetes - Video Available on Investmentpitch.com

October 17, 2019

Sernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in its Phase I/II Clinical Trial for Type-1 Diabetes

October 16, 2019

Sernova Renews Frontier Flex for Canadian Investor Relations and Marketing

September 17, 2019

Sernova Completes Oversubscribed Private Placement of $4,684,564

September 10, 2019

Sernova Announces Second Closing of Private Placement

September 3, 2019

Sernova Announces First Closing of Private Placement

August 19, 2019

Sernova Announces Up to $3 Million Private Placement Financing

July 25, 2019

Sernova's Phase I/II US Clinical Trial for Type-1 Diabetes Advances Following Positive Preliminary Safety and Efficacy Data

July 17, 2019

Sernova Corp Presents Positive Preliminary Safety and Efficacy Data in its Phase I/II Clinical Trial for Type-1 Diabetes

July 3, 2019

Sernova's Principal Investigator to Present Interim Data from the Company's Ongoing Phase I/II Cell Pouch Clinical Trial at the 17th World Congress of the International Pancreas and Islet Transplant Association

June 27, 2019

Sernova Corp Announces Appointment of Deborah Brown to its Board of Directors

May 21, 2019

Sernova Announces Collaboration to Advance Therapeutic Cell Pouch Technologies for the Treatment of Hypothyroidism

April 30, 2019

Sernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical Study for Diabetes

April 11, 2019

Sernova Corp Announces First Patient Implanted with Sernova's Cell Pouch(TM) in a Phase I/II US Clinical Trial for the Treatment of Hypoglycemia Unawareness in Subjects with Type 1 Diabetes

February 11, 2019

Sernova Announces the Appointment of Dr. David Lillicrap, M.D. to its Scientific Advisory Board

January 30, 2019

Sernova to Participate on Diabetes Panel and Present at NobleConXV, 15th Annual Investor Conference January 28th - 29th, 2019

January 28, 2019

Sernova Announces Successful Enrollment Approaching 50% of Subjects in its U.S. Phase I of II Cell Pouch Diabetes Clinical Trial

January 17, 2019

Decks in 2019